Wolverine Asset Management’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
LCM
OFM
Wolverine Asset Management's NUVB Position: Q3 2025 in Review
Wolverine Asset Management sold out of Nuvation Bio (NUVB) in Q3 2025, closing a stake of 4,069 shares — an estimated $7.93K sold.
Wolverine Asset Management first reported a position in NUVB in Q3 2020 and held it in 17 quarters. The position peaked at $532K in Q3 2020. 203 funds tracked by Wall St. Rank hold NUVB as of Q3 2025.
- Wolverine Asset Management reported no remaining Nuvation Bio position as of Q3 2025 after selling out during the quarter.
- Wolverine Asset Management sold 4,069 Nuvation Bio shares in Q3 2025, an estimated $7.93K.
- Wolverine Asset Management first reported a position in Nuvation Bio in Q3 2020 and held it in 17 quarters.
- Wolverine Asset Management's Nuvation Bio position peaked at $532K in Q3 2020.
- 203 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2025.
Based on Wolverine Asset Management's 13F filing for Q3 2025, filed 28 Oct 2025.